| mRNA |
PLX4720 |
CTRPv2 |
pan-cancer |
AAC |
0.21 |
5e-08 |
| mRNA |
selumetinib:piperlongumine (8:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.18 |
5e-06 |
| mRNA |
selumetinib:UNC0638 (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.17 |
7e-06 |
| mRNA |
selumetinib:PLX-4032 (8:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.17 |
2e-05 |
| mRNA |
Erlotinib |
CTRPv2 |
pan-cancer |
AAC |
0.16 |
4e-05 |
| mRNA |
dabrafenib |
GDSC1000 |
pan-cancer |
AAC |
-0.12 |
5e-05 |
| mRNA |
GSK1120212 |
CTRPv2 |
pan-cancer |
AAC |
0.2 |
8e-05 |
| mRNA |
ML334 diastereomer |
CTRPv2 |
pan-cancer |
AAC |
0.18 |
0.0001 |
| mRNA |
selumetinib:MK-2206 (8:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.14 |
0.0002 |
| mRNA |
dabrafenib |
CTRPv2 |
pan-cancer |
AAC |
0.19 |
0.0002 |